为什么湿疹会增加哮喘的风险
Why eczema increases the risk of asthma in patients
研究发现,湿疹患者的皮肤炎症会通过淋巴结引发 basophils(嗜碱性粒细胞)激活,进而导致肺部对过敏原的敏感性增加,最终可能诱发哮喘。抑制 basophils 的生成可显著减轻哮喘症状。研究人员认为,通过阻断 basophils 的远程效应,未来可能开发出预防哮喘的新策略。
People with eczema often develop allergic asthma during the course of their lives. The reason for this is still largely unclear. Two publications from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) now turn the spotlight on certain immune cells, known as basophils, as the link between skin and lung conditions.
In a study published in Allergy, the researchers suppressed the production of basophils while the irritated skin was exposed to an allergen. Consequently, the resulting inflammatory reaction did not lead to hypersensitivity in the animals' lungs toward the same allergen. Their subsequent review article published in Frontiers in Immunology discusses the broader implications of these findings for asthma prevention.
Eczema, also known as atopic dermatitis, is one of the most common skin diseases. It usually begins during infancy or early childhood. The cause is not yet fully understood. However, allergens from animal hair, house dust or pollen can trigger flare-ups of the condition. "Atopic eczema disrupts the skin barrier, enabling substances from the environment to enter the body more easily," explains Dr. David Vöhringer, director of the Department of Infection Biology at Universitätsklinikum Erlangen.
As children grow up, they often additionally develop allergic asthma or food allergies. All these conditions are known as "atopic" diseases that are characterized by hypersensitivity of the skin or mucous membranes. "In medicine, the development of these diseases is often referred to as an atopic march," says Dr. Daniel Radtke, head of the study and co-author of both publications with his team member Dr. E Da Choi and Vöhringer. "What causes allergic sensitization to spread to other organs is not yet fully understood."
No basophils, no asthma—at least in mice
The research group recently showed, however, that certain immune cells, the basophils, play an important role in the atopic march. They are produced by stem cells in the bone marrow and normally circulate in the blood. When the skin is irritated by a foreign substance, the basophils cross the blood vessel wall and migrate to the affected tissue. There they release signaling molecules that activate other immune cells. The result is an inflammatory response.
"We applied an allergen to the skin of mice with atopic dermatitis symptoms and simultaneously suppressed the formation of basophils for a short period," explains Radtke. When the animals later inhaled the allergen, the lungs showed only a weak inflammatory response. In a control group in which the team had not suppressed basophil production, the response was markedly stronger—similar to a severe asthma attack.
The exact communication pathway is still unknown
"This shows that basophils in the skin cause the lung to become hypersensitive to the allergen as well," says Radtke. "We do not yet know how this happens." A signaling molecule called interleukin‑4 may play an important role. It is released in large amounts by basophils when they are activated by an allergen, and it amplifies the immune response. Components of this strong immune response can reach the airways via the bloodstream and put the local immune system or the cells lining the bronchi on heightened alert.
In their newly published review article, the researchers point out that their findings could also lead to new preventive strategies against asthma. "It is very important to treat allergic skin reactions quickly and effectively in early childhood," emphasizes Vöhringer. "This is because prolonged or very strong activation of basophils could significantly increase the risk of asthma."
It may also be possible to specifically block the "remote effect" of this activation. To do this, it is important to determine the molecular pathways through which the cells communicate with the lung.
Drugs are currently being developed and tested that reduce interleukin‑4 production by basophils. The primary goal is to use these agents to relieve the skin condition and its extremely unpleasant itching. "Perhaps it may also be possible to reduce the risk of patients developing asthma later in life with these agents," hopes Vöhringer. "Whether that is the case remains to be seen."
Publication details
E Da Choi et al., From skin to lung: basophil-mediated spread of allergic diseases, Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1916940
Journal information: Frontiers in Immunology , Allergy
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Why eczema increases the risk of asthma in patients (2026, November 10) retrieved 10 November 2026 from https://medicalxpress.com/news/2026-11-eczema-asthma-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com